VITALE's Scientific Poster at SLAS Europe 2025

At this year’s SLAS Europe 2025, innovation, automation, and Life-Science excellence took center stage and EFEVRE TECH LTD was proudly among the pioneers leading the way. As part of our commitment to transparency, scientific engagement, and open innovation, our very own Robotic Software Engineer, Marios Konstantinou, represented the company with a powerful scientific poster presentation, introducing the world to AMGEL4TT; our next-generation modular automation workstation, and its integration software with the transformative VITALE software platform. ​This momentous event not only showcased EFEVRE TECH’s technological leadership, but also significantly propelled the development and visibility of the VITALE project across the European scientific and clinical research communities.

EFEVRE TECH’s participation in the SLAS Europe 2025 International Conference & Exhibition was made possible through the prestigious SLAS Travel Award, a recognition granted to selected innovators and researchers whose work contributes meaningfully to the advancement of laboratory automation and life-sciences. This award provided financial support and visibility, enabling Marios Konstantinou to attend and present VITALE's work. As recipients of the award, EFEVRE TECH had the opportunity to showcase the VITALE platform through a dedicated scientific poster session, highlighting its unique capabilities. The award not only affirmed the scientific and technological merit of the project, but also provided a valuable platform for networking with industry leaders, engaging with potential collaborators, and receiving expert feedback. 

VITALE Scientific Poster: A Platform Designed to Revolutionize Workflows

At the heart of the poster presentation was the VITALE software as well as the AMGEL4TT robotic automation platform, engineered to automate and streamline high-throughput EDTA blood processing, DNA extraction, and next-generation sequencing (NGS). The fully modular and scalable workstation reduces human error and operator dependency while enhancing reproducibility and compliance in both research and diagnostic environments. ​From barcode scanning and fluorometric quantification to cloud-hosted LIMS integration and real-time data tracking, VITALE is designed to offer remote access with true walk-away automation, supporting over 24 hours of uninterrupted processing. This poster drew attention not only for its technical depth but also for the bold vision it offers: future-proof molecular workflows.

Our scientific VITALE poster presentation focused on a critical biomedical challenge: The automated detection of clonal hematopoiesis (CH), a condition linked to acute myeloid leukemia (AML) and cardiovascular disease. We introduced AMGEL4TT, a high-throughput workstation capable of automating every step of blood sample processing, DNA extraction, and next-generation sequencing (NGS) library preparation, along with its unique control software platform VITALE, our AI-powered control and analysis software that transforms AMGEL4TT into a smart laboratory system. 

Key features of AMGEL4TT and VITALE presented in the poster included:

• Fully Automated sample-to-sequencing workflow using blood EDTA samples.

• Modular Design supporting up to 48 samples per run and walk-away automation for >24 hours.

• Seamless Command of the AMGEL4TT device for hands-free operation.

• Protocol Customization through a visual and user-friendly protocol designer.

• Automatic Literature Comparison via AI insights using PubMed-indexed publications.

• Digital Documentation with the personal laboratory notebook and scheduling calendar. 

By bridging automation hardware with intelligent software, the combined system sets a new standard for genomic workflow reproducibility and speed, which is critical for both research and diagnostic applications in hematology and cardiology.

This scientific poster, authored by Marios Konstantinou, Rafaella Hadjicosti, and Dimitris Kyriakou, received positive feedback from researchers across Europe. It underscored our vision to empower life-science labs with flexible, scalable, and intelligent automation that adapts to evolving research needs.

Boosting VITALE: From Software Concept to Clinical Enabler

Society for Laboratory Automation and Screening (SLAS) Europe 2025 served as a powerful launchpad for VITALE, especially due to its scientific and academic-oriented audience attending. Marios Konstantinou’s presentation along with Dr. Dimitris Kyriakou's attendance as an expert researcher, ignited cross-disciplinary conversations about the value of flexible automation, and how the integration of VITALE into AMGEL4TT positions it as a game-changer in life-science laboratories.

This exposure triggered interest from potential collaborators and early adopters, affirming the relevance of VITALE in today’s fast-evolving biomedical landscape. The presentation helped validate our approach to modular automation and intelligent software control, an approach that’s now drawing attention across Europe’s research and diagnostic sectors.

Our presence at SLAS Europe 2025 wasn’t just a showcase, it was a strategic catalyst. The insights and connections gained at this event have helped us refine user feedback loops, attract new collaborators, and better position the VITALE-AMGEL4TT duo for commercialization and clinical piloting.

The response to our poster entitled "Versatile Automation for IVDR Method Development in CH Detection" was overwhelmingly positive. Attendees recognized its alignment with the urgent clinical need for scalable Clonal Hematopoiesis (CH) detection, especially in the context of acute myeloid leukemia (AML) and cardiovascular risk stratification.

Looking Ahead: Building Scientific Trust, One Connection at a Time

This milestone event marked a turning point for the proposed VITALE project. By engaging with Europe’s leading scientists, innovators, and thought leaders, we are now better equipped to move from TRL 4 to TRL 6, expanding clinical testing while ensuring regulatory alignment and scientific robustness. SLAS Europe 2025 reaffirmed our belief: the future of genomic medicine belongs to platforms that combine automation, adaptability, and intelligence. 

​​​​The Project with the proposal number ENTERPRISES/0223/Sub-Call1/105 and project acronym VITALE is funded by the European Union Recovery and Resilience Facility of the NextGenerationEU instrument, through the Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation.